Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2025-12-28 @ 2:05 PM
Study NCT ID:
NCT05443568
Status:
COMPLETED
Last Update Posted:
2025-10-06
First Post:
2022-06-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Israel, as Part of Local Clinical Practice
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-09
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-16
Completion Date Type:
ACTUAL
First Submit Date:
2022-06-29
First Submit QC Date:
None
Study First Post Date:
2022-07-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-02
Last Update Post Date:
2025-10-06
Last Update Post Date Type:
ESTIMATED